Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
出版年份 2017 全文链接
标题
Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-12-13
DOI
10.1038/s41467-017-02390-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents
- (2017) Haihua Xiao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates
- (2017) Thomas H. Pillow et al. Chemical Science
- Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity
- (2016) Jonathan C. Barnes et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Recent advances in the construction of antibody–drug conjugates
- (2016) Vijay Chudasama et al. Nature Chemistry
- Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
- (2016) James Haley et al. Oncotarget
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Disulfide-Based Multifunctional Conjugates for Targeted Theranostic Drug Delivery
- (2015) Min Hee Lee et al. ACCOUNTS OF CHEMICAL RESEARCH
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer
- (2015) David Pépin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Bispecific small molecule-antibody conjugate targeting prostate cancer
- (2013) C. H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody Therapeutics in Cancer
- (2013) M. X. Sliwkowski et al. SCIENCE
- One-step synthesis of water dispersible silica nanoplates
- (2012) Hong Chen et al. CHEMICAL COMMUNICATIONS
- Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery
- (2012) Ruogu Qi et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Defining principles of combination drug mechanisms of action
- (2012) J. R. Pritchard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems
- (2011) Arati Sharma et al. Expert Opinion on Drug Metabolism & Toxicology
- Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies
- (2011) Antonio Gualberto EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- A mammalian functional-genetic approach to characterizing cancer therapeutics
- (2010) Hai Jiang et al. Nature Chemical Biology
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small-molecule delivery by nanoparticles for anticancer therapy
- (2010) Zhuo (Georgia) Chen TRENDS IN MOLECULAR MEDICINE
- Small-molecule-directed nanoparticle assembly towards stimuli-responsive nanocomposites
- (2009) Yue Zhao et al. NATURE MATERIALS
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started